A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa
Clinical trial NCT04213261 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04213261
- Sponsor
- Castle Creek Biosciences, LLC.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-09
- Primary completion
- 2023-01-17
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.